Market Overview

UPDATE: Citigroup Downgrades Comerica to Sell on Valuation, Interest Rate Exposure

Share:
Related CMA
3 Stocks That Could Benefit As Fed Considers Easier Stress Tests For Regional Banks
Comerica Shares Upgraded By Goldman, Added To 'Conviction Buy' List
Latest stress test changes bad news for TBTFs, good news for smaller players (Seeking Alpha)

Citigroup downgraded Comerica (NYSE: CMA) from Neutral to Sell and raised the price target from $28.00 to $31.00.

Citigroup commented, "We view CMA as an above average bank but, at its current valuation, a bad stock. … Importantly, since the vast majority of CMA's loans price off of the very short-end of the yield curve, CMA really needs short rates to move up in order for its earnings to materially move up. … CMA is pricing in a '14 NIM ~28 bps and ~40 bps above our estimate and the consensus estimate, respectively. In order for that to happen, our model suggests that LIBOR in '14 would have to average ~110 bps versus its current ~29 bps and the implied forward rate of ~48 bps. That scenario would likely require at least a few near-term Fed rate hikes. As such, our sense is that the marginal buyer of CMA at its current valuation will be disappointed."

Comerica closed at $35.32 on Thursday.

Latest Ratings for CMA

DateFirmActionFromTo
Sep 2016Goldman SachsUpgradesNeutralBuy
Sep 2016BarclaysMaintainsUnderweight
Sep 2016CLSAMaintainsOutperform

View More Analyst Ratings for CMA
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (CMA)

View Comments and Join the Discussion!